Negative Expression of DSG1 and DSG2, as Prognostic Biomarkers, Impacts on the Overall Survival in Patients with Extrahepatic Cholangiocarcinoma

<div>Immunohistochemical staining of DSG2, ×200. (a) Positive expression of DSG2, moderately differentiated EHCC. (b) Negative expression of DSG2, well differentiated EHCC. (c) Positive expression of DSG2, pericancerous tissues. (d) The positive expression of DSG2, adenoma.</div>

Analytical Cellular Pathology

fig2

Figure 2

Figure 2: Negative Expression of DSG1 and DSG2, as Prognostic Biomarkers, Impacts on the Overall Survival in Patients with Extrahepatic Cholangiocarcinoma 

Figure 2 | Negative Expression of DSG1 and DSG2, as Prognostic Biomarkers, Impacts on the Overall Survival in Patients with Extrahepatic Cholangiocarcinoma 